Australia is carefully awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://poppyxltn742096.evawiki.com/10648512/this_new_drug_retatrutide_australia_a_potential_hope_for_losing_weight